This invention relates to: (a) a process for preparing compounds and salts thereof that, inter alia, inhibit HCV; (b) compositions comprising such compounds and salts in combination with one or more additional therapeutic agents; and (c) methods of use of such compositions. The compounds are useful in the treatment of hepatitis C and are of the following general structure: Formula (I)